Cyclacel Stock Market Value


USD 1.39  0.01  0.72%   

Cyclacel Pharmaceuti's market value is the price at which a share of Cyclacel Pharmaceuti stock trades on a public exchange. It measures the collective expectations of Cyclacel Pharmaceuti investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Cyclacel Pharmaceuti and determine expected loss or profit from investing in Cyclacel Pharmaceuti over a given investment horizon. Continue to Cyclacel Pharmaceuti Correlation, Cyclacel Pharmaceuti Volatility and Cyclacel Pharmaceuti Alpha and Beta module to complement your research on Cyclacel Pharmaceuti.

Is Cyclacel Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuti. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cyclacel Pharmaceuti is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuti's market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Cyclacel Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cyclacel Pharmaceuti 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cyclacel Pharmaceuti's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cyclacel Pharmaceuti.
No Change 0.00  0.0 
In 1 year 11 months and 22 days
If you would invest  0.00  in Cyclacel Pharmaceuti on October 14, 2020 and sell it all today you would earn a total of 0.00 from holding Cyclacel Pharmaceuti or generate 0.0% return on investment in Cyclacel Pharmaceuti over 720 days. Cyclacel Pharmaceuti is related to or competes with Ajinomoto, JM Smucker, Ajinomoto Inc, Freshpet Inc, Hormel Foods, Grupo Bimbo, and Saputo. Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of canc... More

Cyclacel Pharmaceuti Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cyclacel Pharmaceuti's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cyclacel Pharmaceuti upside and downside potential and time the market with a certain degree of confidence.

Cyclacel Pharmaceuti Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cyclacel Pharmaceuti's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cyclacel Pharmaceuti's standard deviation. In reality, there are many statistical measures that can use Cyclacel Pharmaceuti historical prices to predict the future Cyclacel Pharmaceuti's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cyclacel Pharmaceuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cyclacel Pharmaceuti in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
4 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cyclacel Pharmaceuti. Your research has to be compared to or analyzed against Cyclacel Pharmaceuti's peers to derive any actionable benefits. When done correctly, Cyclacel Pharmaceuti's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cyclacel Pharmaceuti.

Cyclacel Pharmaceuti Backtested Returns

Cyclacel Pharmaceuti appears to be unstable, given 3 months investment horizon. Cyclacel Pharmaceuti secures Sharpe Ratio (or Efficiency) of 0.0885, which signifies that the company had 0.0885% of return per unit of standard deviation over the last 3 months. Our philosophy in foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. By analyzing Cyclacel Pharmaceuti technical indicators you can presently evaluate if the expected return of 0.64% is justified by implied risk. Please makes use of Cyclacel Pharmaceuti's risk adjusted performance of 0.1098, and Mean Deviation of 5.19 to double-check if our risk estimates are consistent with your expectations.
On a scale of 0 to 100, Cyclacel Pharmaceuti holds a performance score of 6. The firm shows a Beta (market volatility) of 0.5033, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Cyclacel's beta means in this case. As returns on the market increase, Cyclacel Pharmaceuti returns are expected to increase less than the market. However, during the bear market, the loss on holding Cyclacel Pharmaceuti will be expected to be smaller as well. Although it is vital to follow Cyclacel Pharmaceuti historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-eight technical indicators for Cyclacel Pharmaceuti, which you can use to evaluate the performance of the firm. Please makes use of Cyclacel Pharmaceuti treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside to make a quick decision on whether Cyclacel Pharmaceuti price patterns will revert.



Insignificant reverse predictability

Cyclacel Pharmaceuti has insignificant reverse predictability. Overlapping area represents the amount of predictability between Cyclacel Pharmaceuti time series from 14th of October 2020 to 9th of October 2021 and 9th of October 2021 to 4th of October 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cyclacel Pharmaceuti price movement. The serial correlation of -0.18 indicates that over 18.0% of current Cyclacel Pharmaceuti price fluctuation can be explain by its past prices.
Correlation Coefficient-0.18
Spearman Rank Test0.23
Residual Average0.0
Price Variance1.72

Cyclacel Pharmaceuti lagged returns against current returns

Autocorrelation, which is Cyclacel Pharmaceuti stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cyclacel Pharmaceuti's stock expected returns. We can calculate the autocorrelation of Cyclacel Pharmaceuti returns to help us make a trade decision. For example, suppose you find that Cyclacel Pharmaceuti stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   

Cyclacel Pharmaceuti regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cyclacel Pharmaceuti stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cyclacel Pharmaceuti stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cyclacel Pharmaceuti stock over time.
   Current vs Lagged Prices   

Cyclacel Pharmaceuti Lagged Returns

When evaluating Cyclacel Pharmaceuti's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cyclacel Pharmaceuti stock have on its future price. Cyclacel Pharmaceuti autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cyclacel Pharmaceuti autocorrelation shows the relationship between Cyclacel Pharmaceuti stock current value and its past values and can show if there is a momentum factor associated with investing in Cyclacel Pharmaceuti.
   Regressed Prices   

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cyclacel Pharmaceuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cyclacel Pharmaceuti's short interest history, or implied volatility extrapolated from Cyclacel Pharmaceuti options trading.

Pair Trading with Cyclacel Pharmaceuti

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyclacel Pharmaceuti position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuti will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Cyclacel Pharmaceuti could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyclacel Pharmaceuti when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyclacel Pharmaceuti - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyclacel Pharmaceuti to buy it.
The correlation of Cyclacel Pharmaceuti is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyclacel Pharmaceuti moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyclacel Pharmaceuti moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyclacel Pharmaceuti can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Cyclacel Pharmaceuti Correlation, Cyclacel Pharmaceuti Volatility and Cyclacel Pharmaceuti Alpha and Beta module to complement your research on Cyclacel Pharmaceuti. Note that the Cyclacel Pharmaceuti information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Cyclacel Stock analysis

When running Cyclacel Pharmaceuti price analysis, check to measure Cyclacel Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuti is operating at the current time. Most of Cyclacel Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cyclacel Pharmaceuti's price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Cyclacel Pharmaceuti technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cyclacel Pharmaceuti technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cyclacel Pharmaceuti trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...